🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free

    Deepflare

    Deepflare provides an AI-powered in silico platform designed to predict T-cell immunogenicity for antigen design. The software integrates proprietary models with open-source computational biology tools to help biotech and pharmaceutical companies de-risk pipelines and optimize vaccine candidates. The platform supports tasks such as increasing solubility and modifying specific protein regions for viral therapies and cancer vaccines.

    Visit websiteWarsaw, Poland
    AI
    Biotechnology
    Healthcare
    SaaS
    Computational Biology

    Funding summary

    Total raised
    €1.5M
    Funding rounds
    1

    Investors in Deepflare

    Investors on record for Deepflare. Click any investor to view their CAPLINK profile and funding criteria.

    Fundraising for a startup like Deepflare?

    Explore CAPLINK's investor database of thousands of active VCs and angels.

    Browse investors

    We use cookies to enhance your experience. Read our Privacy Policy